Results

Total Results: 2,073 records

Showing results for "indication".
Users also searched for: medication reconciliation

161. Disposition of Comments for CER 151 Management of Postpartum Hemorrhage (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hemorrhage-postpartum_disposition-comments.pdf
     April 28, 2015 - proposed interventions in our algorithms and the almost impossible task of dealing with confounding by indication … whereas the other devices mentioned here (Foley, S-B tube, Rusch balloon) are not FDA-cleared for the indication … TEP Reviewer #1 Discussion/ Conclusion Methods for dealing with confounding by indication should

162. Disposition of Comments for CER 168 Infantile Hemangioma (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
     January 15, 2016 - vary depending on clinical presentation and lesion characteristics, but the meta-analyses provides an indication … TEP reviewer #5 Discussion/ Conclusion ES-23/25-28- Neither of these is an indication for steroid … vary depending on clinical presentation and lesion characteristics, but the meta-analyses provides an indication

163. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_research-protocol.pdf
     October 18, 2010 - The methodology to assess ITT, loss to followup, and confounding by indication, is described in more … (2) Potential for confounding by indication was removed from the quality assessment for all … How else would there be confounding by indication were it not because of differences in prognostic

164. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
     February 01, 2008 - Pharmacologic Agents Pharmacol- ogic Class Generic (Name brand) Manufacturer FDA Approved Indication … Inferior Vena Cava Filters Name Manufacturer FDA Approved Indication(s) Stainless Steel Greenfield … Mechanical Devices Name Manufacturer FDA Approved Indication(s) Jobst® Anti-embolism Graduated

165. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
     February 01, 2008 - Pharmacologic Agents Pharmacol- ogic Class Generic (Name brand) Manufacturer FDA Approved Indication … Inferior Vena Cava Filters Name Manufacturer FDA Approved Indication(s) Stainless Steel Greenfield … Mechanical Devices Name Manufacturer FDA Approved Indication(s) Jobst® Anti-embolism Graduated

166. Trends in the use of echocardiography, 2007 to 2011 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/echocardiography_research.pdf
     May 01, 2014 - unwarranted costs to the health care system.”12 The criteria vary by previous service and clinical indication … in gen- eral echocardiography testing is viewed as appropriate to assess conditions that have an indication … Second, claims data do not contain information about the indication for the procedure nor of the test

167. Obesity (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - The approved indication is “as an adjunct to a reduced-calorie diet and increased physical activity … mg (NN8022) is 4 in phase III trials for treating obesity; a new drug application for this indication … The approved indication is as “an adjunct to a reduced-calorie diet and increased physical activity

168. Comparative Effectiveness of Bariatric Surgery and Nonsurgical Therapy in Adults With Metabolic Conditions and a Body Mass Index of 30.0 to 34.9 kg/m² | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/weight-loss-surgery/research-protocol
     December 01, 2019 - surgery devices, manufacturers, and FDA-approved indications Device Manufacturer FDA Approved Indication … FDA-approved indications Pharmacologic Class Generic (Name brand) Manufacturer FDA-Approved Indication

169. AHRQ EPC Program Research Gaps Summary: Women's Health (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/research-gaps-womens-health-22.pdf
     April 01, 2022 - • Systematic reviews of harms (regardless of indication) report that acetaminophen, prednisolone … o Issues related to data reporting, including reporting results separately by indication in both randomized

170. Disposition of Comments for CER 183 Tonsillectomy for OSDB (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tonsillectomy-disposition-170415.pdf
     January 17, 2017 - We consider this study to be confounded by indication. 2. … alone to tonsillectomy alone or adenotonsillectomy as those studies would likely be confounded by indication … addressed T in other pediatric conditions Our Key Questions did not target sickle cell disease as an indication … The studies referenced included children with recurrent throat infection as an indication for tonsillectomy

171. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/11_peptic_ulcer_potential_high_impact_2012-12-111.pdf
     January 01, 2012 - In August 2011, NPS began submitting data for a new drug application to FDA for the same indication … patient education could be necessary before this intervention would become widely diffused for this indication … treating SBS. 61 In December 2011, NPS completed submission of a new drug application for the same indication … A decision was expected from FDA by December 30, 2012. 60 Teduglutide is not approved for any indication

172. Obesity (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - for managing T2DM, has been used off label for treating obesity while the company pursues a labeled indication … If priced similarly to the diabetes indication, this would provide 18, 3 mg doses—the daily dose for … The proposed indication includes patients with BMIs of at least 40 kg/m2 or greater than 35 kg/m2 with … Nonetheless, the manufacturer is pursuing a labeled indication for treating overweight and obesity. … If pricing is similar for the obesity indication, such a carton would provide 18 doses at the 3 mg

173. A Framework for Assessing Quality Indicators for Cancer Care at the End-of-Life | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cancer-quality-indicator-framework/research
     January 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

174. A Framework for Assessing Quality Indicators for Cancer Care at the End-of-Life | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cancer-end-of-life-measures-framework/research
     January 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

175. Developing Quality Indicators for Cancer End-of-Life Care: Proceedings From a National Symposium | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cancer-end-of-life-indicators-symposium/research
     January 01, 2020 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

176. Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
     January 30, 2020 - cluster RCT, clinical trial, cohort study, case-control study), number of participants (study size indication … The domain reporting bias differentiates between suspected bias (e.g., there is indication of publication … Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies … Tdap) Children, adults, pregnant women New dosing (2nd dose in people 10-64 years of age); age indication

177. Improving Medication Safety in High Risk Medicare Beneficiaries Toolkit | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/medication-therapy-management-1/research
     May 01, 2019 - ADE-non-allergic reaction ADE-toxic reaction to the drug A problem with the choice of the drug for the indication … one specific problems exist (e.g. drug not appropriate for patient characteristics (2.1) AND no clear indication … Medication List – regroup by indication, in medical as well as layman's terminology. … Regroup by indication, in layman's terminology.

178. Safety of Vaccines Used for Routine Immunization in the United States | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/safety-vaccines/protocol
     January 01, 2021 - cluster RCT, clinical trial, cohort study, case-control study), number of participants (study size indication … The domain reporting bias differentiates between suspected bias (e.g., there is indication of publication … Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies … (Tdap) Children, adults, pregnant women New dosing (2nd dose in people 10-64 years of age); age indication

179. Transparency of Reporting Requirements: Effectiveness of Treatments Options for the Prevention of Complications and Treatment of Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
     September 01, 2016 - Finally, the full team will consider if the final conclusions are influenced by any indication of reporting

180. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - The developer is conducting phase III trials with AVP-786 and AVP-923 for this indication, and we continue